Large-scale pancreatic cancer detection via non-contrast CT and deep learning
Shanghai Institute of Hematology · Alibaba Group (United States) · +18 more institutions
Abstract
Pancreatic ductal adenocarcinoma (PDAC), the most deadly solid malignancy, is typically detected late and at an inoperable stage. Early or incidental detection is associated with prolonged survival, but screening asymptomatic individuals for PDAC using a single test remains unfeasible due to the low prevalence and potential harms of false positives. Non-contrast computed tomography (CT), routinely performed for clinical indications, offers the potential for large-scale screening, however, identification of PDAC using non-contrast CT has long been considered impossible. Here, we develop a deep learning approach, pancreatic cancer detection with artificial intelligence (PANDA), that can detect and classify…
Citation impact
- FWCI
- 48.44
- Percentile
- 100%
- References
- 62
Authors
36Topics & keywords
- Pancreatic cancer
- Contrast (vision)
- Deep learning
- Scale (ratio)
- Artificial intelligence
- Cancer detection
- Medicine
- Cancer
- Good health and well-being
Funding
- JHJohns Hopkins University
- CGChang Gung Memorial Hospital
- GPGuangdong Provincial Hospital of Traditional Chinese Medicine
- NNNational Natural Science Foundation of ChinaAward: 82372045
- FUFudan University
- TUTianjin University
- CGChang Gung Medical Foundation
- ZUZhejiang University
- TMTianjin Medical University
- VFVšeobecná Fakultní Nemocnice v Praze
- GPGuangdong Provincial People's Hospital
- NINational Institutes of Health
- CICancer Institute and Hospital, Chinese Academy of Medical Sciences
- SOSchool of Medicine, Shanghai Jiao Tong University
- SHShengjing Hospital
- SYSun Yat-sen University Cancer Center
- NCNIH Clinical Center